影响肺癌的瘤微环境中的非免疫细胞成分 免疫疗法
Jingtao Zhang1, Shuai Liu2, Xiubao Chen3
1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250014, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|August 17, 2023
概括
了解肺癌复杂的免疫网络对于改善免疫疗法至关重要. 本综述指导了针对瘤微环境 (TME) 的策略,以获得更好的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 肺癌 (LC) 仍然是全球癌症死亡的主要原因.
- 免疫疗法改变了癌症治疗,改善了反应和生存率.
- 需要进一步了解LC复杂的免疫微环境,以提高免疫治疗的疗效.
研究的目的:
- 审查肺癌瘤微环境 (TME) 中复杂的免疫网络.
- 阐明肺癌细胞使用的免疫逃避机制.
- 为开发针对LC的新型多向免疫疗法策略提供指导.
主要方法:
- 对肺癌免疫学和免疫疗法当前研究的文献综述.
- 对LC中的瘤相关抗原 (TAA) 和瘤特异抗原 (TSA) 的分析.
- 检查免疫逃生机制,包括免疫抑制细胞,细胞因子和TME的作用.
主要成果:
- 液结细胞表达TAA和TSA,启动抗瘤免疫反应.
- 瘤细胞采用免疫逃生机制,产生一种免疫抑制的TME.
- 诸如细胞因子,微生物组,纤维细胞和内皮细胞等因素有助于免疫逃避.
结论:
- 对LC免疫网络的全面了解对于促进免疫疗法的发展至关重要.
- 将免疫疗法与其他治疗方法结合起来,可以产生协同效应.
- 针对TME提供了一个有前途的策略,以提高LC免疫疗法的疗效.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556


